drugset / Trial / NCT00942448

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

NCT00942448

Phase 3 Completed 306 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupDouble-blindTreatment

Summary

The present study is proposed to evaluate the efficacy and safety of single doses of Diclofenac HPBCD subcutaneous (s.c.) (25 mg/1 ml and 50 mg/1 ml) in the treatment of acute moderate-to-severe pain after dental impaction surgery.

Timeline

Start
2009-09
Primary completion
2010-01
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 25 mg/ml Subcutaneous
Comparator Diclofenac Other / unclassified 50 mg/ml Subcutaneous
Comparator Diclofenac Other / unclassified 75 mg/ml Subcutaneous

Indications

No indication recorded.